PASYLATION
LIVE

Serial Number

79126686

Owner

XL-protein GmbH

Attorney

Anthony G. Craig

Filing Date

Oct 17, 2012

Add to watchlist:

No watchlists yet
View on USPTO

PASYLATION Trademark

Serial Number: 79126686 • Registration: 4483086

PASYLATION is a trademark filed by XL-protein GmbH on October 17, 2012. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

XL-protein GmbH (5 trademarks)

Lise-Meitner-Str. 30
Freising 85354 , DE

Entity Type: 03

Trademark Details

Filing Date

October 17, 2012

Registration Date

February 18, 2014

Published for Opposition

December 3, 2013

Goods & Services

Scientific and technological services and research, namely, scientific research, analysis, testing, in the fields of chemistry, genetics, biology, biotechnology and biochemistry; [ technical services, namely, computer diagnostic services in the field of DNA, RNA and protein expression, detection and analysis and respective design services, in particular in the fields of chemistry, genetics, biology, biotechnology and biochemistry; industrial analysis and research services in the field of medical, dental, forensic and scientific research; design and development of computer hardware and software; ] services of a chemical and biochemical laboratory; scientific research including conducting of scientific examinations; and preparation of scientific opinions; quality checking, namely, quality evaluation services for the medical and pharmaceutical industry; [ design and development of programs for data processing; ] consultancy for scientific, laboratory and research purposes in the field of chemistry, genetics, biology, biotechnology and biochemistry; [ scientific services of a technical measuring and test laboratory; ] technological consulting services pertaining to scientific and industrial scientific research in the fields of generation, technical processing and technical analysis of biomaterials and medically relevant data

[ Chemicals and biochemicals for research and laboratory purposes excluding for medical or veterinary purposes, and for industrial and scientific purposes; [ unprocessed artificial resins, unprocessed plastics; ] chemical and biological preparations for medical research and medical and scientific purposes ]

[ Pharmaceutical and veterinary preparations and preparations for human medical purposes for use in treating growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; [ sanitary preparations for medical purposes; dietetic substances adapted for medical use, namely, nutritional supplements containing proteins, peptides, food for babies; preparations for destroying vermin; fungicides, herbicides; ] pharmaceutical and diagnostic preparations for medical [, dental and forensic ] purposes and for purposes of [ forensic medicine and ] laboratory medicine, namely, pharmaceutical and diagnostic preparations for diagnosis, prevention, treatment or cure of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; testing reagents in kit form for medical, [ dental and forensic ] purposes and for purposes of [ forensic medicine and ] laboratory medicine, namely, medical [ and forensic ] diagnostic reagents and assays for testing of body tissues and body fluids; chemical and biotechnological preparations for medical and diagnostic purposes, namely, reagents and solvents for sample preparation, modification and manipulation of cells and for performing of marking, separation, isolation, purification, amplification and/or analytical methods for biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances for diagnostic purposes included in this class; medicaments for preventive, curative and palliative purposes for preventing, treating or curing of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; medical biomarkers, in particular for preventative, diagnostic, prognostic or predictive purposes, namely, polypeptide sequences; [ medical preparations, namely, kits for laboratory medicine in particular for preventive, diagnostic, prognostic or predictive purposes, namely, diagnostic kits consisting primarily of proteins, buffers, and reagents for use in detecting growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; ] biomolecules for medical purposes, namely, proteins, peptides and small molecule drugs with conjugated polypeptide sequences for binding of active substances; medical preparations for analytical purposes, namely, reagents for detecting growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; preparations for health care, namely, for diagnosis, prevention, treatment, or cure of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases ]

Filing History

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Oct 30, 2025 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 8, 2025 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Oct 7, 2024 NA71
REGISTERED-SEC.71 ACCEPTED
Oct 7, 2024 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 7, 2024 APRE
TEAS SECTION 71 RECEIVED
Feb 12, 2024 ES71
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Feb 18, 2023 REM4
INTERNATIONAL REGISTRATION RENEWED
Nov 4, 2022 RNWL
NEW REPRESENTATIVE AT IB RECEIVED
Jul 2, 2022 NREP
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Sep 9, 2021 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 29, 2021 INPR
PARTIAL INVALIDATION PROCESSED BY THE IB
Feb 13, 2021 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jan 1, 2021 INPS
INVALIDATION PROCESSED
Dec 31, 2020 INPC
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Dec 29, 2020 NA75
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Dec 29, 2020 C75P
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Dec 27, 2020 INPR
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Oct 2, 2020 EROP
POST REGISTRATION ACTION MAILED - SEC. 71 & 15
May 12, 2020 PR75
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 6, 2020 APRE
TEAS SECTION 71 & 15 RECEIVED
Feb 18, 2020 ES75
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 18, 2020 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 18, 2020 CHAN
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 18, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 18, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 18, 2020 COAR
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 18, 2019 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jul 13, 2017 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 27, 2014 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 6, 2014 FICS
FINAL DISPOSITION PROCESSED
Jun 6, 2014 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 18, 2014 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 18, 2014 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 3, 2013 NPUB
PUBLISHED FOR OPPOSITION
Dec 3, 2013 PUBO
NOTIFICATION PROCESSED BY IB
Dec 2, 2013 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 13, 2013 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 13, 2013 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 13, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 30, 2013 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 29, 2013 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 26, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 26, 2013 CRFA
ASSIGNED TO LIE
Sep 20, 2013 ALIE
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 19, 2013 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 19, 2013 REAP
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 19, 2013 TROA
REFUSAL PROCESSED BY IB
Apr 23, 2013 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 28, 2013 RFCS
REFUSAL PROCESSED BY MPU
Mar 28, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 28, 2013 RFCR
NON-FINAL ACTION WRITTEN
Mar 27, 2013 CNRT
APPLICATION FILING RECEIPT MAILED
Mar 22, 2013 MAFR
ASSIGNED TO EXAMINER
Mar 18, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 18, 2013 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 15, 2013 REPR